Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.
Key Details
- 1UnitedHealthcare will provide nationwide coverage for Heartflow's CT-based plaque analysis software, effective October 1.
- 2Coverage applies to all UnitedHealthcare plans, including commercial, Medicare Advantage, and dual-eligible offerings.
- 3Heartflow aims to raise up to $212.5 million by offering 12.5 million shares at $15–$17 per share in its IPO.
- 4Company generated about $43 million in Q2 2025, up 40% year-over-year.
- 5Heartflow's platform has assessed over 400,000 patients for coronary artery disease as of March 31, 2025.
- 6The US market opportunity for Heartflow's products is estimated at $5 billion.
Why It Matters
Nationwide insurer coverage and a strong IPO position solidify Heartflow's AI solution as a standard in coronary CT interpretation. This represents a significant step in the adoption and reimbursement of radiology AI, paving the way for broader clinical and commercial implementation.
Source
Radiology Business
Related News
•AuntMinnie
Toronto Study: LLMs Must Cite Sources for Radiology Decision Support
University of Toronto researchers found that large language models (LLMs) such as DeepSeek V3 and GPT-4o offer promising support for radiology decision-making in pancreatic cancer when their recommendations cite guideline sources.
•AI in Healthcare
Nvidia, Amazon Drive AI Expansion Across Genomics and Radiology
Major healthcare and technology companies partner to push AI advancements in genomics, radiology, and broader healthcare.
•Radiology Business
AI Model Uses CT Scans to Reveal Biomarker for Chronic Stress
Researchers developed an AI model to measure chronic stress using adrenal gland volume on routine CT scans.